MyShare
Symbol search
| date | o | news | sym |
| proactiveinvestors 20:35 Wed 7 | CytoDyn set to deliver its leronlimab treatment to critically ill coronavirus (COVID-19) patients in the Philippines CytoDyn Inc (OTCQB:CYDY) announced it is delivering its drug leronlimab to a Philippine hospital to be administered to another 28 critically ill coronavirus (COVID-19) patients under a new Compassionate Special Permit (CSP). The company also said it is negotiating the potential future delivery of 100,000 vials to the Philippines for additional CSP use. Based upon the speedy recovery of the first COVID-19 CSP patient in the Philippines, we are coordinating very closely with Chiral and the regulators to ensure we are expediting as much leronlimab as needed, CytoDyn CEO Nader Pourhassan said in a statement. READ: CytoDyn has multiple shots on goal with its flagship drug Vyrologix to treat for HIV, various cancers and even coronavirus We remain hopeful that all of these coordinated efforts will continue to expand the availability of leronlimab to the Philippines, Pourhassan added. CytoDyn noted that its commercial partner in the Philippines, Chiral Pharma Corporation, is working closely with the Philippine FDA and the hospital. Leronlimab (PRO 140) is a C-C chemokine receptor type 5 (CCR5) antagonist with potential multiple therapeutic indications. CCR5 hampers the ability of a virus to infiltrate immune cells. Aside from COVID-19, the US Food & Drug Administration (FDA) has granted Fast Track designation to CytoDyn for two potential indications of leronlimab for critical illnesses. The first is a combination therapy with HAART for HIV-infected patients and the second is for metastatic triple-negative breast cancer. Contact Sean at sean@proactiveinvestors.com https://www.proactiveinvestors.com/companies/news/945969/cytodyn-set-to-deliver-its-leronlimab-treatment-to-critically-ill-coronavirus-covid-19-patients-in-the-philippines-945969.html | CYDY Healt |
Text search
| date | o | news | |
| proactiveinvestors 15:00 Thu 15 | CytoDyn strikes agreement with Chiral Pharma to supply up to 200K vials of leronlimab to critically ill coronavirus patients in the Philippines CytoDyn Inc (OTCQB:CYDY) announced that it has executed an exclusive supply and distribution agreement with Chiral Pharma Corporation to supply up to 200,000 vials of leronlimab to critically ill coronavirus (COVID-19) patients in the Philippines. Chiral has been working diligently with the Philippine FDA to ensure the regulatory path is cleared so we can provide leronlimab to thousands of critically ill COVID-19 patients under CSP authorization, CytoDyn CEO Nader Pourhassan said in a statement. Upon quick recovery of the first Filipino patient critically ill with COVID-19 treated with leronlimab, Chiral is continuously receiving CSP requests and is hoping to accelerate the availability of leronlimab under CSP to thousands of critically ill COVID-19 patients. READ: CytoDyn says its coronavirus long-haulers trial now fully enrolled faster than expected Pourhassan added: In parallel, we are using data generated from our CD12 open-label extension to pursue EUAs in multiple countries experiencing surges in critically ill COVID-19 patients. The Company will accelerate manufacturing of leronlimab at Samsung BioLogics upon such approval. After completing two clinical trials with COVID-19 patients (a Phase 2 and a Phase 3), CytoDyn has initiated a Phase 2 investigative trial for post-acute sequelae of SARS COV-2 (PASC), also known as COVID-19 Long-Haulers. This trial will evaluate the effects of leronlimab on clinical symptoms and laboratory biomarkers to further understand the pathophysiology of PASC. It is currently estimated that between 10-30% of those infected with COVID-19 develop long-term symptoms such as fatigue, cognitive impairment, sleep disorders, and shortness of breath. If this trial is successful, CytoDyn said it plans to pursue clinical trials to evaluate leronlimabs effect on immunological dysregulation in other post-viral syndromes, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The US Food and Drug Administration (FDA) has granted CytoDyn Fast Track designation to explore two potential indications using leronlimab to treat HIV and metastatic cancer. The first indication is combination therapy with HAART for HIV-infected patients, and the second is for metastatic triple-negative breast cancer (mTNBC). Leronlimab blocks CCR5, a cellular receptor important in HIV infection, tumor metastases, and other diseases, including NASH (nonalcoholic steatohepatitis). The CCR5 receptor also appears to play a central role in modulating immune cell trafficking to sites of inflammation. Contact the author: patrick@proactiveinvestors.com Follow him on Twitter @PatrickMGraham | CYDY Healt | |
| nbcnews 16:31 Fri 16 TrdId | Brazil in need of sedatives for critically ill Covid patients Brazil got an emergency shipment of sedatives needed to intubate severely ill COVID-19 patients as it records the world's highest daily Covid death toll. | ||
| sciencedaily 13:08 Thu 15 Nws | An ion pump to deliver chemotherapy agents to the brain Despite surgery and subsequent treatment with chemotherapy and radiation, the majority of patients experience recurrence of malignant brain tumors. Researchers have shown in cells in culture that an ion pump can deliver drugs more accurately, which gives less severe adverse effects in chemotherapy. | ||
| prnewswire:443 14:54 Fri 16 Nws | St. Luke's Provides Treatment for COVID 'Long Haulers' BETHLEHEM, Pa., April 16, 2021 /PRNewswire/ -- St. Luke's is pleased to introduce its new COVID Recovery Clinic, a program dedicated to the treatment of post-COVID-19 patients with lingering symptoms. St. Luke's recognizes the prevalence of 'long COVID' symptoms and the need to care for... | ||
| sciencedaily 18:28 Thu 15 Nws | Treatment not always needed to prevent vision loss in patients with elevated eye pressure The national Ocular Hypertension Treatment Study was designed to determine whether lowering elevated eye pressure in patients might prevent vision loss from glaucoma. Researchers recently completed follow-up studies on patients 20 years after the start of the original study and found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma. | ||
| abc net au 23:54 Thu 15 Nws | Brisbane company trials new drug on US COVID-19 patients in bid to curb severe reactions A Brisbane biotech company createsan anti-inflammatory drug which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States in a bid to prevent people dying from the virus. | ||
| @htTweets 00:00 Sun 18 Nws | Two Covid patients share one bed, some sleep on floor while getting oxygen treatment at Sassoon hospital in Pune
( https://t.co/6FK40g1jbh - | BBBY Consu | |
| skynews 22:46 Thu 15 Nws | Patients 'tied to beds and intubated without sedatives' as COVID crisis worsens in Brazil Hospitals in Brazil are being forced to intubate coronavirus patients without sedatives amid critical medicine shortages caused by the country's current outbreak, reports claim. | ||
| skynews 22:46 Thu 15 Nws | Brazil's COVID crisis worsens as patients 'tied to beds' and ventilated without sedatives Hospitals in Brazil are being forced to intubate coronavirus patients without sedatives amid critical medicine shortages caused by the country's current outbreak, reports claim. | ||
| @IndiaToday 30m ago Nws | #Delhi CM urges Centre to amplify oxygen supply for treatment of Covid patients. Centre hits back at Delhi CM for m https://t.co/UbnUbaFRH2 - | ||
| globenewswire 18:00 Fri 16 Nws | Shriners Hospitals for Children and The Jackson Laboratory Announce Research Affiliation to Discover Causes of Cerebral Palsy The two organizations will work with a large set of data derived from CP patients and their families with the goal of uncovering potential new methods of diagnosis and treatment The two organizations will work with a large set of data derived from CP patients and their families with the goal of uncovering potential new methods of diagnosis and treatment | ||
| prnewswire:443 15:54 Fri 16 Nws | FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer SILVER SPRING, Md., April 16, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction... | ||
| @IndiaToday 02:00 Sun 18 Nws | PM Modi reviews Covid-19 situation, vaccine drive, stresses on 'testing, tracking, treatment'
#Coronavirus https://t.co/DZZYNOprbB - | ||
| globenewswire 20:04 Fri 16 Nws | CYDY CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds CytoDyn Inc. Shareholders of Securities Fraud Class Action Lawsuit RADNOR, Pa., April 16, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Western District of Washington against CytoDyn Inc. (OTCMKTS: CYDY) (CytoDyn) on behalf of those who purchased or acquired CytoDyn common stock between March 27, 2020 and March 9, 2021 , inclusive (the Class Period). | CYDY Healt | |
| @IndiaToday 11:16 Sun 18 Nws | Dr. Singh, in his letter, said the lives of many patients undergoing treatment are in 'danger' due to the crisis of https://t.co/T4zpRx765M - | ||
| bbci co uk 12:08 Fri 16 Nws | Muckamore Abbey Hospital: Seven to face prosecution They were reported to prosecutors for offences including the alleged ill-treatment of patients. | ||
| cnn 21:41 Fri 16 TrdId | Rapidly intensifying Typhoon Surigae nears Philippines Typhoon Surigae, known in the Philippines as Bising, has rapidly intensified over the past 24 hours and will make a close brush of the Philippines over the weekend. CNN Meteorologist Jennifer Gray has the forecast. | ||
| bbci co uk 12:32 Fri 16 Nws | Muckamore Abbey Hospital: Seven face prosecution over abuse claims They were reported to prosecutors for offences including the alleged ill-treatment of patients. | ||
| marketwatch 10:48 Fri 16 | Eli Lilly asks FDA to revoke EUA for COVID antibody treatment alone to speed transition to combination therapy Eli Lilly and Co. said Friday it is seeking a revocation of the emergency use authorization granted by U.S. regulators for its bamlanivimab antibody treatment for COVID-19 alone in order to complete the transition to bamlanivimab and etesevimab together. 'Lilly made this request due to the evolving variant landscape in the U.S. and the full availability of bamlanivimab and etesevimab together,' the company said in a statement. The combination has proved to be more effective in neutralizing the COVID-19 variants that have been detected in the U.S. after first emerging in the U.K., South Africa and Brazil, and that are more infectious than the original virus. The combination is also better at treating the rapidly growing B.1.427/B.1.429 California strain that currently accounts for 50% of virus cases in California and over 10% of cases in other states. 'In the U.S., bamlanivimab alone should no longer be administered. However, sites of care should not dispose of bamlanivimab supply; instead, they should order etesevimab to pair with it,' said Lilly. Bamlanivimab was the first neutralizing monoclonal antibody to receive an EUA from the FDA as a treatment for mild to moderate COVID-19 and more than 400,000 patients have been given it. Lilly estimates that has prevented more than 20,000 hospitalizations and at least 10,000 deaths during the peak of pandemic cases. Lily expects that in collaboration with Amgen Inc. , it can manufacture sufficient supply of the two antibodies to meet global supply needs. Lilly shares were up 0.6% premarket, and have gained 10% in the year-to-date, matching the S&P 500's gains. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news. | LLY Healt | |
| washingtonpost 11:48 Thu 15 | What We Know About the Impact of Covid-19 on Children Young children typically are superspreaders of respiratory germs, so its puzzling that they dont seem to be major transmitters of the coronavirus that causes Covid-19. Theyre also relatively absent among hospitalized patients. Initially, that was thought to be because theyre less likely to become seriously ill if infected. Later studies indicate that those of primary school age, at least, may be less likely to catch the virus in the first place. Still, theyre not immune to an array of ind | ||
| prnewswire:443 15:30 Fri 16 TrdId | Pinnacle Treatment Centers Breaks Ground On Addiction Treatment Campus in Southcentral Indiana MARTINSVILLE, Ind., April 16, 2021 /PRNewswire/ -- Pinnacle Treatment Centers, a leader in providing accessible, affordable treatment for individuals struggling with substance abuse, broke ground last week on a comprehensive treatment campus and recovery community in Martinsville, Indiana.... | ||
| @ABSCBNNews 08:00 Fri 16 Nws | The Philippines logs 10,726 additional coronavirus cases on Friday, April 16.
Total now at 914,971, with 193,476 a https://t.co/ZPp4BNzjdN - | ||
| @ABSCBNNews 08:08 Sun 18 Nws | The Philippines logs 10,098 additional coronavirus cases on Sunday, April 18.
Total now at 936,133, with 141,089 a https://t.co/4QSJ3bNuUq - | ||
| news google au 08:52 Thu 15 NwsRmrs | Coronavirus: Concerns over locally made AstraZeneca vaccine | 9 News Australia - 9 News Australia Coronavirus: Concerns over locally made AstraZeneca vaccine | 9 News Australia 9 News Australia NSW woman dead from blood clots after COVID-19 vaccination NEWS.com.au Coronavirus patients much more likely to get blood clots than vaccine recipients 9News Editorial: All drugs come with risk. The COVID vaccines are no different Los Angeles Times Scott Morrison and health authorities warn Australians not to jump to conclusions over blood clots The Guardian View Full coverage on Google News | ||
| forbes 18:31 Fri 16 Nws | The Race To Keep Antibody Treatments One Step Ahead Of Covid-19 Variants Antibody therapies have been a key tool in keeping patients out of hospitals, but drug companies are fighting to stay ahead of coronavirus mutations. | ||
| bbci co uk 23:37 Thu 15 NwsRmrs | India coronavirus: Desperate Covid-19 patients turn to black market for drugs Amid a punishing second wave, people across India are finding drugs, oxygen and beds in short supply. | ||
| sciencedaily 15:41 Thu 15 Nws | Patients who are overweight or obese at risk of more severe COVID-19, study finds Patients who are overweight or obese have more severe COVID-19 and are highly likely to require invasive respiratory support, according to a new international study. | ||
| cnn 08:06 Fri 16 TrdId | Typhoon Surigae may bring heavy rain and high wind gusts to the Philippines Typhoon Surigae, known in the Philippines as Typhoon Bising, continues to strengthen as it heads towards the Philippines bringing the chance of heavy rain and high winds. CNN meteorologist Derek Van Dam has the forecast. | ||
| nytimes 02:49 Sat 17 Nws | We Were Flying Blind: A Dr.s Account of a Womans J.&J. Vaccine-Related Blood Clot Case The disorder is rare, but so severe that the vaccine is on hold while experts weigh the risks and alert doctors and patients about symptoms and treatment. | ||
| indiatoday intoday in 06:42 Sun 18 Nws | Lack of oxygen claims lives of 12 Covid patients in MP's Shahdol; official denies shortage MP: Oxygen shortage claims lives of 12 Covid patients at Shahdol Medical College |